Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody-Reference-Cited by-同舟云学术

Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody

Published:2016-08-25 Issue:40 Volume:28 Page:8912-8920
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Wang Chao¹²,Sun Wujin¹²,Wright Grace¹²,Wang Andrew Z.¹²³,Gu Zhen¹²⁴

Affiliation:

1. Joint Department of Biomedical Engineering; University of North Carolina at Chapel Hill and North Carolina State University; Raleigh NC 27695 USA

2. Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery; Eshelman School of Pharmacy; University of North Carolina at Chapel Hill; Chapel Hill NC 27599 USA

3. Department of Radiation Oncology; University of North Carolina; Chapel Hill NC 27599 USA

4. Department of Medicine; University of North Carolina School of Medicine; Chapel Hill NC 27599 USA

Funder

NC TraCS

National Institutes of Health

UNC cancer center

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Reference53 articles.

1. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

2. Metastasis as an evolutionary process

3. Inflammation and necrosis promote tumour growth

4. Excisional surgery for cancer cure: therapy at a cost

5. The effects of surgery on tumor growth: a century of investigations

Cited by 305 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies;Advanced Materials;2024-09-12

2. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies;Pharmaceutics;2024-08-16

3. Adjuvant Delivery Method and Nanoparticle Charge Influence Peptide Amphiphile Micelle Vaccine Bioactivity;2024-06-12

4. NK-92 cells labeled with Fe3O4-PEG-CD56/Avastin@Ce6 nanoprobes for the targeted treatment and noninvasive therapeutic evaluation of breast cancer;Journal of Nanobiotechnology;2024-06-05

5. Core-shell nanomedicine based on multifunctional tetrahedral DNA nanostructures for synergistic enhancement of tumor chemodynamic/chemo-immunotherapy;Chemical Engineering Journal;2024-06